194 related articles for article (PubMed ID: 36691359)
1. Cancer cell-derived novel periostin isoform promotes invasion in head and neck squamous cell carcinoma.
Wenhua S; Tsunematsu T; Umeda M; Tawara H; Fujiwara N; Mouri Y; Arakaki R; Ishimaru N; Kudo Y
Cancer Med; 2023 Apr; 12(7):8510-8525. PubMed ID: 36691359
[TBL] [Abstract][Full Text] [Related]
2. Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells
Park JJ; Hah YS; Ryu S; Cheon SY; Cho HY; Kim JP; Won SJ; Lee JS; Hwa JS; Seo JH; Chang HW; Kim SY
Anticancer Res; 2020 May; 40(5):2627-2635. PubMed ID: 32366407
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
4. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Schinke H; Shi E; Lin Z; Quadt T; Kranz G; Zhou J; Wang H; Hess J; Heuer S; Belka C; Zitzelsberger H; Schumacher U; Genduso S; Riecken K; Gao Y; Wu Z; Reichel CA; Walz C; Canis M; Unger K; Baumeister P; Pan M; Gires O
Mol Cancer; 2022 Sep; 21(1):178. PubMed ID: 36076232
[TBL] [Abstract][Full Text] [Related]
5. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
[TBL] [Abstract][Full Text] [Related]
7. Catulin Based Reporter System to Track and Characterize the Population of Invasive Cancer Cells in the Head and Neck Squamous Cell Carcinoma.
Karpińska K; Gielata M; Gwiazdowska A; Boryń Ł; Kobielak A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008571
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
9. Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.
Kudo Y; Iizuka S; Yoshida M; Nguyen PT; Siriwardena SB; Tsunematsu T; Ohbayashi M; Ando T; Hatakeyama D; Shibata T; Koizumi K; Maeda M; Ishimaru N; Ogawa I; Takata T
PLoS One; 2012; 7(8):e44488. PubMed ID: 22952986
[TBL] [Abstract][Full Text] [Related]
10. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
11. MMP-10/stromelysin-2 promotes invasion of head and neck cancer.
Deraz EM; Kudo Y; Yoshida M; Obayashi M; Tsunematsu T; Tani H; Siriwardena SB; Keikhaee MR; Qi G; Iizuka S; Ogawa I; Campisi G; Lo Muzio L; Abiko Y; Kikuchi A; Takata T
PLoS One; 2011; 6(10):e25438. PubMed ID: 21998657
[TBL] [Abstract][Full Text] [Related]
12. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
[TBL] [Abstract][Full Text] [Related]
13. Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR‑26a‑5p.
Hu W; Zhao Y; Su L; Wu Z; Jiang W; Jiang X; Liu M
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34435652
[TBL] [Abstract][Full Text] [Related]
14. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
[TBL] [Abstract][Full Text] [Related]
15. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer.
Kudo Y; Ogawa I; Kitajima S; Kitagawa M; Kawai H; Gaffney PM; Miyauchi M; Takata T
Cancer Res; 2006 Jul; 66(14):6928-35. PubMed ID: 16849536
[TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
Wang S; Chen X; Qiao T
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylated SPANXA1/A2 promotes the metastasis of head and neck squamous cell carcinoma.
Li J; Bo H; Zhu F; Li Q; Chen T; Lei S; Fan L
Med Oncol; 2020 Nov; 37(12):112. PubMed ID: 33175201
[TBL] [Abstract][Full Text] [Related]
18. Upregulated miR‑411‑5p levels promote lymph node metastasis by targeting RYBP in head and neck squamous cell carcinoma.
Zhang C; Wang H; Deng M; He L; Ping F; He Y; Fan Z; Cheng B; Xia J
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33537835
[TBL] [Abstract][Full Text] [Related]
19. Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7.
Yu B; Wu K; Wang X; Zhang J; Wang L; Jiang Y; Zhu X; Chen W; Yan M
Cell Death Dis; 2018 Oct; 9(11):1082. PubMed ID: 30348980
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma.
Zhu M; Zhang C; Chen D; Chen S; Zheng H
Biomed Pharmacother; 2019 Sep; 117():108998. PubMed ID: 31207579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
